𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Measuring serum levels of glycosaminoglycans for prediction and using viscum fraxini-2 for treatment of patients with hepatocellular carcinoma

✍ Scribed by Al-Gayyar, Mohammed M.H.; Ebrahim, Mohamed A.; Shams, Mohamed E.E.

Book ID
122282997
Publisher
Elsevier
Year
2013
Tongue
English
Weight
367 KB
Volume
7
Category
Article
ISSN
0974-6943

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 1-2 trial of PTK787/ZK222584 combi
Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma : Implication for antiangiogenic approach to hepatocellular carcinoma
✍ Thomas Yau; Pierre Chan; Roberta Pang; Kelvin Ng; S. T. Fan; Ronnie T. Poon πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 265 KB

## Abstract ## BACKGROUND: This phase 1‐2 trial assessed the efficacy and tolerability of an oral angiogenesis inhibitorβ€”PTK787/ZK222584 (PTK)β€”in combination with intravenous doxorubicin for the treatment of advanced hepatocellular carcinoma (HCC) patients. ## METHODS: In phase 1, advanced HCC p

Clinical significance of the measurement
Clinical significance of the measurement of hepatic blood flow using xenon 133 and balloon catheter in patients undergoing treatment for hepatocellular carcinoma
✍ Souichiro Miyauchi; Yoshifumi Yasuhara; Yasuyuki Ohta πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 553 KB

Total hepatic blood flow and portal blood flow were measured separately using a modified xenon 133 clearance method during angiography in 71 patients with chronic liver diseases, including 40 with proven hepatocellular carcinoma, and in 12 patients without detectable chronic liver injury who served